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Abstract
Background: Aging and latent infection with Cytomegalovirus (CMV) are thought to be major factors driving the
immune system towards immunosenescence, primarily characterized by reduced amounts of naïve T-cells and
increased memory T-cells, potentially associated with higher morbidity and mortality. The composition of both
major compartments, γδ as well as αβ T-cells, is altered by age and CMV, but detailed knowledge of changes to the
γδ subset is currently limited.
Results: Here, we have surveyed a population of 73 younger (23–35 years) and 144 older (62–85 years) individuals
drawn from the Berlin Aging Study II, investigating the distribution of detailed differentiation phenotypes of both
γδ and αβ T-cells. Correlation of frequencies and absolute counts of the identified phenotypes with age and the
presence of CMV revealed a lower abundance of Vδ2-positive and a higher amount of Vδ1-positive cells. We found
higher frequencies of late-differentiated and lower frequencies of early-differentiated cells in the Vδ1+ and Vδ1-Vδ2-,
but not in the Vδ2+ populations in elderly CMV-seropositive individuals confirming the association of these
Vδ2-negative cells with CMV-immunosurveillance. We identified the highest Vδ1:Vδ2 ratios in the CMV-seropositive
elderly. The observed increased CD4:CD8 ratios in the elderly were significantly lower in CMV-seropositive individuals,
who also possessed a lower naïve and a larger late-differentiated compartment of CD8+ αβ T-cells, reflecting the
consensus in the literature.
Conclusions: Our findings illustrate in detail the strong influence of CMV on the abundance and differentiation pattern
of γδ T-cells as well as αβ T-cells in older and younger people. Mechanisms responsible for the phenotypic alterations
in the γδ T-cell compartment, associated both with the presence of CMV and with age require further clarification.
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Background
Aging is accompanied by a dysregulation of the im-
mune response with implications for health [1].
Developmentally-programmed thymic involution caus-
ing reduced release of naïve T-cells in adults results
in the characteristic accumulation of memory T-cells
and reduction of naïve T-cells over the lifecourse [2].
Protection against new infections is impaired due to a
reduced naïve T-cell repertoire, and control of previously-
encountered pathogens may be impaired by senescence of
the memory cells. Thus, accumulation of memory T-cells
and reduction of naïve T-cells are commonly taken as
hallmarks of immunosenescence, although they mostly
reflect adaptive responses [3]. Similar shifts in propor-
tions of memory T-cells are seen as a result of infec-
tion with Cytomegalovirus (CMV) [4], suggesting the
presence of the latter as one of the major factors
contributing to this phenomenon. Infection with this
widespread β-herpesvirus is usually asymptomatic, and es-
tablishes occult latency. Nonetheless, primary infections
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or re-infections with this virus can be life-threatening for
immunocompromised people or newborns, indicating that
CMV is a powerful pathogen requiring immune control.
Infected individuals possess serum antibodies specific for
CMV and are thus referred to as CMV-seropositive. The
majority of infected people present with expanded mem-
ory phenotype CD8+ T-cell populations, and may have a
higher risk of coronary heart disease associated with vas-
cular inflammation [5, 6] or diabetes [7]. Seroprevalence
depends on age and socio-economic factors. A study of
24,260 Germans yielded a seroprevalence of 46 % in the
age range 18–60 years with a yearly conversion rate of
0.55 % (http://www.rki.de/DE/Content/Infekt/EpidBull/
Merkblaetter/Ratgeber_Zytomegalievirus.html). Hence,
there is a chance of becoming infected with CMV at
any time of life, and the proportion of the population
that is infected thus increases with age.
Surveys of T-cell biomarkers for immune monitoring
purposes commonly focus on the most prominent T-cell
subset, expressing T cell receptors (TCR) for antigen
composed of αβ chains and mostly either CD4 or CD8
co-receptors. Age-associated as well as CMV-associated
differences are well-recognized in both subsets, but
more markedly in the CD8+ subset [1–4]. Lower
frequencies of CD8+ naïve T-cells and higher propor-
tions and absolute numbers of late-stage differentiated
CD8+ T-cells expressing CD45RA (sometimes desig-
nated “TEMRA” cells) are commonly taken as key-
markers of immune aging [4]. In the Swedish OCTO-
study of people 85 years old at baseline, an inverted
CD4:CD8 ratio of <1 resulting from an accumulation of
large numbers of CD8+ TEMRA cells was associated
with poorer survival at 2-, 4- and 6–year follow-up [8].
At the other extreme, the Belgian BELFRAIL study asso-
ciated a CD4:CD8 ratio >5 resulting from large numbers
of naïve CD4+ T-cells with poorer health and more
frailty at follow-up [9] and with worse 3-year survival in
women (Adriaensen et al., manuscript in preparation).
Other studies in different cohorts are also examining
the influence of these αβ T-cell-based variables on health
and survival in the elderly. However, in addition to the
well-described αβ T-cells, a second discrete subset of
T-cells is present in the peripheral blood of all indi-
viduals. These cells express a completely different TCR
composed of γδ not αβ chains, and which are mostly
CD4- and CD8-double negative (with a minor CD8+
population [10]). Limited TCR polymorphism, especially
in the δ chains, and lack of MHC-restriction for antigen
recognition position these cells somewhere between
innate and adaptive immunity [11]. In healthy adults
1–10 % of all peripheral T-cells carry this TCR. Ana-
logous to the presentation of peptides via MHC
molecules to the αβ TCR, glycolipids are presented
via CD1 to γδ T-cells [12, 13]. The majority of the γδ
T-cells in peripheral blood express the δ2 chain, a
minority the δ1 chain [14], and other much smaller
populations express other δ-chains. Those γδ T-cells
expressing the Vδ2 isoform recognize small phosphoanti-
gens derived from the non-mevalonate pathway or the iso-
prenoid biosynthesis [15, 16] (stress, pathogen or tumor-
associated), alkylamines [17] or synthetic aminobispho-
sphonates [18, 19]. In contrast, Vδ1 cells recognize
stress-induced ligands such as MICA, MICB [20], or
EPCR [21]. In the context of aging, there are few studies
on γδ T-cells reporting that their abundance in peripheral
blood is reduced in the elderly [22, 23]. A considerable in-
crease of γδ T-cells during active CMV infection has been
reported [24], which potentially associates these cells with
anti-CMV immune responses, as shown by many
others [25–27]. As the proportion of the population
infected with CMV increases with age, this could
counteract the age-associated decrease. The purpose of
the present study was to survey a younger and older popu-
lation to seek age-associated differences in peripheral γδ
T-cells, taking this effect of CMV infection into account.
Moreover, we have analyzed the main γδ T-cell compart-
ments (Vδ1+, Vδ2+ and Vδ1-Vδ2-) separately because
CMV infection and aging result jointly in an increased
pool of Vδ2-negative cells [23, 26, 28–30] with altered
memory phenotype distributions [31, 32]. We previously
showed an association of the Vδ2-negative cells with anti-
CMV IgG-titers [32]. This may be related to the antibody-
dependent anti-CMV activity of Vδ2-negative γδ T-cells
dependent on their CD16 expression [29] and their recog-
nition of other stress-induced molecules [33]. We there-
fore included CD16 in the present phenotypic analysis
focused particularly on γδ T-cells in a younger and
older population drawn from the Berlin Aging study II
(BASE-II) to determine age- and CMV-associated al-
terations at the cellular level. These results emphasize
the impact of CMV infection on most αβ and γδ T-cell
subsets, including the rarely-studied CD8+ γδ T-cells.
Results
T-cell phenotypes in the context of age and CMV
Large scale surveys of the proportions and differenti-
ation phenotypes of γδ T-cells in cross-sectional studies
of younger and older populations are scarce. Taking ad-
vantage of the Berlin BASE-II study, here we have
undertaken detailed phenotyping of peripheral γδ T-cells
in 73 younger and 144 older individuals, in relation to
their CMV-serostatus. At the same time, we assessed
similar parameters for the αβ T-cell subset in compari-
son in order to confirm the expected normalcy of this
population with regard to established T-cell biomarkers.
Using advanced flow cytometry and the standardized
OMIP-20 panel specifically designed for accurately de-
termining γδ T-cell phenotypes [34], we analyzed a total
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of 217 individuals. These data are summarized in Fig. 1,
which displays the distribution of all major memory-
differentiation stages (vertical columns), for each individ-
ual tested (horizontal lines). The frequencies of each
phenotype are color-coded (high being red, low blue and
white absent). The upper part of the figure depicts the
effect of age on CMV-seronegative individuals, with age
increasing from top to bottom, whereas the lower part
of the figure shows the same for CMV-seropositive
subjects. Dominant effects of CMV-seropositivity are
observed in terms of higher total frequencies of the
Vδ1+ compartment and lower frequencies in the Vδ2+
compartment, whereas lower proportions of the CD8+
compartment reveal jointly the effects of the factors
age and CMV-seropositivity as influences on their
abundance (Fig. 1). Notably, there are higher frequencies
of the late-differentiated phenotypes (CD27-CD28-
CD45RA +CD16-) in the CD8+ and Vδ1+ T-cells of
CMV-seropositive individuals. As the white-colored areas
indicate, the expression of CD16 in the γδ T-cell compart-
ment is limited only to some very early- and very late-
differentiated memory subsets. The following sections will
describe differences in phenotypic abundance and abso-
lute cell counts in greater detail.
Composition of the T-cell compartments is associated
with age and CMV-serostatus
The highest proportions of γδ T-cells were found in
young CMV-seronegative individuals, at a median fre-
quency of 3.8 % of all CD3+ T-cells and a median abso-
lute count of 51 cells/μL blood. This was significantly
different in older individuals, independent of their
Fig. 1 Detailed distribution of αβ T-cell and γδ T-cell compartments and differentiation phenotypes. Each line reflects frequencies of a single individual,
color-coded. Red indicates high values, blue low. The first part of the heat map describes the CD4+ and CD8+ αβ T-cells (blue background) and their
differentiation status displayed in columns and characterized by the expression of CD27 (purple), CD28 (turquoise), CD45RA (orange) and CD16 (green),
whereas white indicates the absence of the individual markers. The second part of the heat map describes the abundance of the Vδ1+, Vδ2+ and
Vδ1-Vδ2- γδ T-cell compartments and their differentiations signatures. The black lines in the coding-table for the differentiation markers
show the frequencies of the parental compartments. The heat map is horizontally divided into CMV-seronegatives (CMV-) in the upper and
seropositives (CMV+) in the lower part. Both parts are further stratified for subject age
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CMV-serostatus (first lines of each section comparing
young seronegative with old seropositive and seronega-
tive individuals in Additional file 1: Table S1: p = 0.0052,
p < 0.0001 respectively and Additional file 1: Table S4:
p = 0.0006, p < 0.0001 respectively). For reference pur-
poses, additional tables (Additional file) show in detail
the p values of the Mann-Whitney comparisons of
the 4 groups and the median frequency/counts of the
latter on all identified cellular populations.
γδ T-cells in peripheral blood were classified into
Vδ2+, Vδ1+ or the pool of other γδ T-cells carrying
neither (Vδ1-Vδ2-). Most γδ T-cells are predomin-
antly Vδ2+ in younger subjects, independent of their
CMV-serostatus. The same is true in older CMV-sero-
negatives but not in CMV-seropositives (blue sections in
Fig. 2a and Additional file 1: Figure S1). The latter have a
nearly equal proportion of Vδ2+ and Vδ1+ cells (37.9 and
32.9 %, or median values of 10 and 8 cells/μL blood, re-
spectively). Fig. 2c displays a gradual reduction of the me-
dian frequencies of the Vδ2+ compartment starting with
young CMV-seronegative with the highest frequencies,
then old CMV-seronegatives, young CMV-
seropositives and finally the older CMV-seropositive
subjects who have the lowest frequencies. There is a
reciprocal increase of the Vδ1+ compartment (Fig. 2d;
for statistical evaluation, see Additional file 1: Table S1).
As a group, young and old CMV-seronegatives were not
significantly different from one another in this respect,
although some of the older individuals had much higher
frequencies of this cell type. Statistical significance was
achieved, however, for the comparison of the frequen-
cies in old and young CMV-seronegatives vs old
seropositives showing CMV as an enhancing factor of
age-associated alterations (Fig. 2c: p < 0.0001 for both).
A
B
C D E F
Fig. 2 Phenotypic distribution of the Vδ1+, Vδ2+ and Vδ1-Vδ2- γδ T-cell subsets in young and old CMV seropositive and seronegative individuals.
(a) Median frequencies of the three subsets in the total γδ T-cells and (b) in the CD8+ group of γδ T-cells. Detailed differences are shown be-
tween young (y) and old (o) CMV-seropositives and seronegatives of Vδ2+ cells (c), Vδ1+ cells (d), Vδ1-Vδ2- cells (e) and the Vδ1:Vδ2 ratio (f). The
Mann–Whitney test was used for the statistical comparison. Bonferroni-correction adjusted the significance cutoff to p≤ 0.0083
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Similar patterns were identified when analyzing abso-
lute cell counts (Additional file 1: Table S4), but statis-
tical evaluation revealed a slightly different scenario:
Lower counts of Vδ2+ cells were found in the old, re-
gardless of CMV-serostatus compared to young sero-
negative (Additional file 1: Table S4). Young subjects,
regardless of their CMV-serostatus, have more Vδ1+
cells than old CMV-seronegatives (Additional file 1:
Table S4) whereas old CMV-seropositives have the
highest count of all and significantly higher counts
than old seronegative individuals (Additional file 1:
Table S4, p < 0.0001). Relative frequencies of the
double-negative Vδ1-Vδ2- compartment did not differ
significantly (Fig. 2e), although we did find higher ab-
solute counts in the young CMV-seronegative and old
CMV-seropositive compared to old CMV-seronegative
subjects (Additional file 1: Table S4). Significantly
higher ratios were observed in CMV-seropositive old
compared to old or young seronegative subjects
(Fig. 2f and Additional file 1: Table S1 and S4, p < 0.0001
for all).
About 4.9–10 % of all γδ T-cells express CD8 on the
surface. We observed a higher frequency of these in old
CMV-seropositive individuals, compared to old or
young CMV-seronegatives (Additional file 1: Table S2,
p = 0.0008 and p = 0.0002, respectively). In contrast to
the entire γδ T-cell compartment, the majority of
CD8+ γδ T-cells express the Vδ1 TCR (Fig. 2b). In
the elderly there were significantly higher frequencies
of CD8 + Vδ2+ cells in CMV-seronegatives than in
seropositives (Additional file 1: Table S2, p = 0.0026).
A shift in the proportions when comparing young
CMV-seronegative with young CMV-seropositive, old
CMV-seronegative or old CMV-seropositive individuals
points towards a higher CD8 +Vδ1+ compartment as
identified for the total Vδ1+ cells (Fig. 2b vs Additional
file 1: Table S2). Highest proportions of the Vδ1-δV2-
pool where identified in young CMV-seronegatives, com-
pared to old, independent of the latter’s CMV-serostatus
(Fig. 2b; Additional file 1: Table S2, p = 0.0002 compar-
ing old and young seronegatives and p = 0.0005, old
seropositives with young seronegatives).
Turning to the αβ T-cell subset, young CMV-
seronegative subjects have a lower abundance of these
compared to the old, independent of the latter’s CMV-
serostatus (p = 0.0076 and p < 0.0001, respectively, Fig. 3a
and Additional file 1: Table S4). We observed higher fre-
quencies of CD4+ T-cells in the elderly than in the
young, regardless of their CMV-serostatus (Fig. 3b) and
reciprocally lower frequencies of CD8+ T-cells in the
elderly, again independent of CMV serostatus (Fig. 3c).
However, the CMV+ elderly have significantly lower
frequencies of CD4+ T-cells than the CMV-negative
elderly (p < 0.0001, Fig. 3b) and reciprocally, the CMV+
elderly have significantly higher frequencies of CD8+ T-
cells than the CMV-negative elderly (Fig. 3c, p < 0.0001).
The same pattern of significant differences was found for
absolute counts in the CD8+ T-cell subset (Additional
file 1: Table S4). However, no significant differences were
observed for absolute CD4+ T-cell counts (Additional
file 1: Table S4), consistent with the known greater
effect of CMV on CD8+ than CD4+ T-cells. Accord-
ingly, the CD4:CD8 ratio calculated on the basis of
either counts or frequencies was greatly increased in
old compared to young subjects, but interestingly this
was only statistically significant in CMV-seronegative
subjects (Fig. 3d, p < 0.0001). Old CMV-seropositives had
lower values than old seronegatives (Fig. 3d, p < 0.0001)
but higher than young CMV-seronegative individuals
(Fig. 3d, p = 0.0003). Finally, young CMV-seropositives
had lower numbers than old CMV-seronegative subjects
(Fig. 3d, p < 0.0001).
Memory cell subsets vary in abundance within the T-cell
classes and phenotypes, showing different associations
with age and CMV
Memory cell subsets were identified by the presence
or absence of CD27, CD28 and CD45RA. CD27 +
A B C D
Fig. 3 Age and CMV associated differences in the αβ T-cell compartment. (a) Frequencies of αβ T-cells, identified as γδ TCR negative, in young (y)
and old (o) CMV seropositive and seronegative individuals. (b) The abundance of CD4+ and (c) of CD8 T-cells. (d) CD4:CD8 ratios. The Mann–Whitney
test was used for the statistical comparison. Bonferroni-correction adjusted the significance cutoff to p≤ 0.0083
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CD28 + CD45RA+ T-cells are considered to be early-
differentiated, whereas CD27-CD28-CD45RA+ cells
are very late-differentiated. In addition, each memory
cell subset in the γδ T-cell compartment was analyzed
for expression of the Fcγ III Receptor (CD16). γδ T-cells
that have CD16 on their surface were previously described
to be in involved in antibody-dependent anti-CMV
immunity in a γδ TCR-independent manner [29]. We
found that the diversity of memory phenotypes in the
γδ T-cell compartments is similar to the CD8+ αβ T-cells,
unlike in the CD4+ αβ T-cell subset (see overview dis-
played in Fig. 4). The latter consisted mainly of early-
differentiated phenotypes in the elderly as well as the
young, and with only slightly more differentiated cells
even in CMV-seropositive elderly (Fig. 4). Within the γδ
T-cell compartment, the Vδ2+ cells mainly showed an
earlier-differentiated phenotype, in contrast to the Vδ1+
cells or the pool of the other (Vδ1-Vδ2-) γδ T-cells that
revealed high proportions of later-differentiated cells
(Fig. 4, upper panels). Analysis stratifying subjects accord-
ing to CMV or age did not reveal any significant dif-
ferences in the Vδ2+ compartment, neither for early-
(CD27 +CD28 +CD45RA+CD16-) nor late-differentiated
(CD27-CD28-CD45RA+CD16-) subsets (Additional file 1:
Table S1). However, we observed lower frequencies of
CD27 + CD28 + CD45RA-CD16- cells in young CMV-
seronegative compared to old CMV-seropositive subjects
(Additional file 1: Table S1 and Figure S2: p = 0.0004).
Regardless of the age and independent of CD16 ex-
pression, CMV-seropositives had significantly lower
proportions of CD27 + CD28-CD45RA+ cells compared
to young seronegative individuals, indicating an associ-
ation with the presence of CMV (Additional file 1:
Table S1 and Figure S2). A clear age-associated differ-
ence was only observed when comparing CD27 +
CD28-CD45RA + CD16- cells in young and old CMV-
seronegative subjects (Additional file 1: Table S1 and
Figure S2, p < 0.0001).
Fig. 4 Differentiation-scheme of the entire identified γδ T-cell and αβ T-cell compartments. Each cellular compartment (lines) is represented by a
pie-chart for young and old CMV-seropositive (CMV+) and seronegative (CMV-) individuals. The γδ T-cell compartment is shown with a
blue background, the αβ T-cells with a white background. The single differentiation statuses are color coded in the pie charts, using
green for early- and red for late-differentiated phenotypes
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The main observations in the Vδ1+ memory compart-
ment were that there were lower proportions of early-
differentiated (CD27 + CD28 + CD45RA + CD16-) and
reciprocally higher proportions of late-differentiated
(CD27-CD28-CD45RA + CD16-) cells in young CMV-
seronegative compared to old, regardless of the CMV-
status of the latter (Additional file 1: Table S1 and
Figure S3, p < 0.0001 for all). The same was true for old
CMV-seropositive compared to old seronegative individ-
uals (Table S1, p = 0.0045 and p < 0.0001 respectively).
Additionally, higher frequencies of late-differentiated cells
even in the young CMV-seropositive subjects relative
to seronegatives of the same age-group were found
(Additional file 1: Table S1 and Figure S3, 0.0018)
suggesting an accumulation of late-differentiated cells
in CMV-seropositives. Significantly reduced frequencies
were observed comparing young CMV-seronegatives
with old seropositives for the minor compartments with
the phenotypes CD27 + CD28 + CD45RA-CD16-, CD27 +
CD28-CD45RA + CD16- and CD27 + CD28-CD45RA-
CD16-. The same reduction was found for the latter
phenotype comparing old CMV-seronegative and sero-
positive subjects. Furthermore, a greater abundance of the
CD27 + CD28-CD45RA +CD16- phenotype was identi-
fied in young CMV-seronegative than in young or old
seropositives. However, no statistically significant dif-
ferences were identified between young and old CMV-
seronegatives for the latter phenotype (Additional file 1:
Table S1 and Figure S3). No CD27-CD28+ phenotypes
were detectable, neither for the Vδ1+ nor the other γδ T-
cells (Vδ1-Vδ2-) (Additional file 1: Figure S3 and S4).
The memory phenotype distribution of the pool of
other γδ T-cells (Vδ1-Vδ2-) (Additional file 1: Figure S4)
revealed patterns similar to the Vδ1+ compartment
(Additional file 1: Figure S3). Again, significantly
higher frequencies of the early-differentiated (CD27 +
CD28 + CD45RA + CD16-) and reciprocally lower
abundance of the late-differentiated compartments
(CD27-CD28-; independent of the expression of
CD45RA, and even identified on the CD45RA +CD16+
cells) were found comparing young CMV-seronegative
with old subjects regardless of the latter’s serostatus
(Additional file 1: Table S1). Lower frequencies were
identified in the effector cell compartment of old sero-
positive subjects compared to young CMV-seronegative
with individuals for the phenotypes CD27 + CD28 +
CD45RA-CD16-, CD27 + CD28-CD45RA + CD16- and
CD27 +CD28-CD45RA-CD16- (Additional file 1: Table S1,
p = 0.0071, p = 0.0005, p < 0.0001 respectively). Significantly
lower frequencies of the latter were observed as well
when comparing young with old CMV-seropositives.
Again, we identified lower frequencies of the CD27 +
CD28-CD45RA +CD16- phenotype in old compared to
young CMV-seronegatives (Additional file 1: Table S1).
For the discrimination of the CD8+ γδ T-cell memory
phenotype only the expression of CD27 and CD28
was considered, as these cells were too low in abun-
dance for further subdivision. There were then too
few CD8+ Vδ2+ T-cells for an analysis of the memory
phenotypes at all, but the CD8+ Vδ1+ compartment
(Additional file 1: Figure S5 A and Table S2) revealed
similar differentiation patterns compared to the total
Vδ1+ γδ T-cells (Fig. 4 compared to Additional file 1:
Figure S3 and Table S1), namely, significantly higher
frequencies of early-differentiated (CD27 + CD28+)
cells in young CMV-seronegatives compared to the
old, regardless of their serostatus (Additional file 1:
Table S2: p < 0.0001). Reciprocally, significantly higher
frequencies of late-differentiated cells (CD27-CD28-)
were seen when comparing old CMV-seropositive with
seronegative individuals (in young and old) (Additional
file 1: Figure S5 A and Table S2). The effector pheno-
type CD27 + CD28- was significantly higher in the
young CMV-seronegatives than in the old individuals,
regardless of their CMV-serostatus. Again a similar
pattern was observed for the pool of the other CD8+ γδ
T-cells (Vδ1-Vδ2-) (Additional file 1: Table S2 and
Figure S5 B) compared to the same subset in all γδ T-
cells (Fig. 4). Young CMV-seronegatives had higher
proportions of early-differentiated cells than old
CMV-seropositives or seronegatives, but comparing
young and old seropositives showed that the latter
have lower frequencies of those cells. Again, a higher
abundance was found for the late-differentiated pheno-
type (CD27-CD28-) comparing both groups of older
individuals with young CMV-seronegatives. Young
CMV-seropositives had significantly higher frequencies
of these cells than seronegatives of the same age, as
also identified for the CD8 + Vδ1+ compartment
(Additional file 1: Figure S5 A and B). The Vδ1-Vδ2-
CD8+ compartment was the only one that showed
higher frequencies of the rare phenotype CD27-CD28+ in
the elderly, independent of the presence of CMV, com-
pared to the young CMV-seronegative subjects.
CD8+ αβ T-cells revealed the most differences in
memory phenotype distribution as expected (Fig. 4,
lower panels). Lower frequencies of early-differentiated
and higher frequencies of late-differentiated cells were
found in older and CMV-seropositive subjects (Additional
file 1: Figure S6 and Table S3: either trends or statistical
significance was observed for all comparisons). A gradual
CMV-dominated pattern was only identified comparing
the late-differentiated phenotypes (CD27-CD28-CD16-,
independent of the CD45RA-expression) whereas a joint
influence of age and CMV was observed for the early-
differentiated cells (CD27 + CD28 + CD45RA +CD16-)
(Additional file 1: Figure S6). Highest median frequencies
were identified in the effector cell compartments in older
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CMV-seronegative individuals, suggesting CMV as a
driving force towards accumulated late-differentiated
and a diminished effector cell compartment in the elderly
CMV-seropositive individuals. Statistical analyses, dis-
played in Additional file 1: Table S3, indicate that in
addition to the major increase of the late-differentiated
CD8+ compartment, memory phenotypes of the CD4+
cells do show similar patterns at a lower level. Interest-
ingly, the small, very late-differentiated CD4+ subset
(CD27-CD28-CD45RA + CD16-) was present essen-
tially only in old CMV-seropositive compared to
CMV-seronegative subjects (Additional file 1: Table S3,
p < 0.0001 for both and Additional file 1: Figure S7).
Similar to the CD8+ compartments of less-differentiated
cells, no gradual patterns for the CD4+ compartment were
identified with the exception of the CD27-CD28-
CD45RA-16- cells (Additional file 1: Figure S7). Age-
dependent effects seem to dominate this compartment of
T-cells with a large early differentiated/effector cell
compartment.
Discussion
We present in this study a comprehensive and highly
detailed analysis of the whole peripheral blood T-cell
compartment in 73 younger and 144 older individuals
drawn from the BASE-II study [35]. The present paper
reports the results of an analysis of one-tenth of the total
BASE-II cohort, already a large population to be sub-
jected to this level of detailed immune cell phenotyping.
We confirm the generally-acknowledged robust effects
of age and CMV infection on the abundance and mem-
ory phenotype distribution of many T-cell compartments
with an emphasis on the less well-studied γδ T-cell sub-
sets. For this purpose, the advanced, well standardized
and established flow cytometry panel, published as
OMIP-20 [34], was employed.
T-cell subsets
There are many reports describing differences in the αβ
T-cells in younger and older individuals. Here, we report
that aging is associated with a higher abundance of
CD4+ and less CD8+ αβ T-cells. In the elderly,
CMV-seropositive subjects possessed a smaller CD4+
and a larger CD8+ compartment compared to sero-
negative individuals. Thus, we confirm the presence
of a latent CMV-infection as a factor that alters the αβ
T-cell distribution towards a signature that is described
in young subjects. The CD4:CD8 ratio reflects these
findings: a significantly lower ratio was found in CMV-
seropositive than seronegative elderly, although the
latter still had a higher ratio than young CMV-seronega-
tives. This illustrates the independent effects of age
and CMV infection, suggesting a potentially positive
effect of CMV in our elderly cohort. Interestingly,
Adriaensen at al. [9] reported recently that a
CD4:CD8 ratio >5 was only present in the elderly in
the BELFRAIL study, never in the young, caused by a
shrinking CD8+ compartment. This phenotype was
naïve T-cell dominated, with less late-differentiated
CD8+ T-cells, lower CMV-specific IgG titers and worse
physical condition [9], as well as poorer 3-year survival
(manuscript in preparation). These intriguing data are
consistent with a requirement for vigorous CMV-specific
immunosurveillance to ensure good health and survival in
later life, as suggested by results from our earlier study on
the Leiden 85-Plus population [36]. This is also consistent
with later follow-up studies from the Swedish NONA-
study where none of those individuals who survived to
become nonagenarians and centenarians had an inverted
CD4:CD8 ratio, suggesting selection against individuals
with this characteristic [37].
The other main T-cell compartment, the γδ T-cell
population, is underrepresented in investigations regard-
ing associations with aging and the chronic stimulation
through persistent CMV infections, and this was the
main focus of our present report. In infections, γδ T-
cells seem to respond earlier than αβ T-cells, suggesting
that they are part of the “first line of defense” and the
initiation of an inflammatory response. Consistent with
this notion, γδ T-cells are potent producers of pro-
inflammatory cytokines like IL-17, IFNγ and TNF [38].
There are several studies associating certain sub-groups
of γδ T-cells with anti-CMV immunity [24, 25, 33].
Previous observations report a reduction of the total γδ
T-cell compartment that is associated with chronological
aging [39], whereas a primary CMV infection causes a
marked increase of these cells [24]. This observation is
similar to what is seen in the CD8+ αβ T-cell compart-
ment, which is also reduced with chronological aging,
but can be increased through induction of clonal expan-
sion by pathogens [4]. Several studies show that Vδ2-
negative γδ T-cells correlate with both aging and latent
CMV infection [31, 32]. Interestingly, many of the stud-
ied γδ T-cell clones possessing reactivity against CMV-
infected cells as also show reactivity against transformed
cells (for example [27]). This observation suggests the
recognition of an ensemble of endogenous molecules
that are upregulated in both responses to infections and
cellular dysregulation [38].
The Vδ2-negative subset can be subdivided into the
Vδ1+ compartment and the pool of others (Vδ1-Vδ2-),
as we did in this study. We show that the frequency in
the elderly of the Vδ1+ T-cells and not the pool of other
γδ T-cells (Vδ1-Vδ2-) is markedly affected by CMV-
seropositivity, although this is not the case for absolute
cell counts. In contrast the hypothesis of a beneficial
dual-reactivity of γδ T-cells (against transformed and
CMV-infected cells) [40], we reported recently a
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negative association of the Vδ1+ compartment with the
overall survival of late-stage melanoma patients [41].
The Vδ2+ compartment is reported to be lower in the
elderly than the young [31]. These cells are associated
mostly with pathogen challenges, infectious diseases and
even tumor-induced stress via for example phosphoanti-
gens of the non-/mevalonate pathway [42, 43]. The
present study demonstrates that the gradual reduction of
the Vδ2+ cells is not necessarily due to an gradual in-
crease of the Vδ1+ compartment (significance was not
achieved for all cases) as shown by examining the three
different sub-groups of γδ T-cells. This observation is
similar to what is described for the balance between
CD4+ and CD8+ αβ T-cells. The fact that there is a dir-
ect correlation between the two prominent γδ T-cell
subsets, age and CMV-seropositivity on the single sub-
ject level is shown through the alteration of the Vδ1:Vδ2
ratio. We show that this ratio is significantly increased
in elderly CMV-seropositive individuals. Increased values
for this ratio are also found in melanoma patients
[41, 44], suggesting a potentially prominent role of
these cells in triggering immune responses.
The presence or absence of CD8 is another confound-
ing factor; while most likely not needed for activation
through the γδ TCR, it defines a sub-group of γδ T-cells
that mostly express the δ1 isoform and others (Vδ1-
Vδ2-) of the γδ TCR. Further investigation of the mean-
ing and functional capacity of this γδ T-cell is required.
Memory phenotypes of the different T-cell subsets
The abundance of the identified memory phenotypes of
the αβ T-cell compartment confirms the common
consensus. Reduced proportions of naïve CD8+ cells
were found in the elderly. Higher frequencies of late-
differentiated cells (CD27-CD28-CD45RA + CD16-)
mostly in the CD8+ compartment were identified in the
old subjects, with the greatest difference found in the
old CMV-seropositives compared to all other groups, as
reported previously [4, 45–47]. High proportions of
these late-differentiated CD8+ memory cells are re-
ported to recognize CMV associated antigens, but not
antigens of other persistent herpesviruses [48].
Our findings in the CD4+ compartment show, besides
slight reduction of proportions of the early-differentiated
cells, higher proportions of late differentiated cells
(CD27-CD28-CD45RA +CD16-) in old CMV-seropositive
subjects. This population was clearly identifiable and con-
firms the findings earlier reported on T-cell distribution in
the BASE-II study [49] although the existence of this sub-
set is controversial. This accumulation of CD4+ TEMRA
cells in old CMV-seropositive individuals can be set in the
context of chronological stimulation through CMV and
the resulting T-cell immune response, and is very rarely
seen in CMV-seronegatives.
The application of the memory differentiation model
on γδ T-cells, rather than αβ T-cells, reveals a pattern
that is comparable to the memory phenotype distribu-
tion in the CD8+ αβ T-cell compartment. We analyzed
additionally all subsets for expression of CD16 as the
latter is described as a γδ TCR-independent trigger by
opsonized CMV virions and seems to be involved in effi-
cient inhibition of replication [29]. Especially the Vδ2+
compartment displays a heterogeneous pattern of a var-
iety of different memory phenotypes – the composition
of the latter differs dominantly when comparing young
and old regardless of their CMV serostatus. However, we
identified one exception: the rarely described effector
memory phenotypes CD27 + CD28-CD45RA + CD16+
and CD27 + CD28-CD45RA + CD16- were affected by
both CMV and age. This finding requires further investi-
gation, as usually the Vδ2+ compartment is not de-
scribed as being involved in anti-CMV-immunity.
The identified signatures in the Vδ2-negative compart-
ment that was subdivided here into Vδ1+ and Vδ1-Vδ2-
cells, also revealed influences of both age and CMV on
lowering the abundance of early-differentiated pheno-
types. We saw marked increases of late-differentiated
phenotypes in both groups, associated with both age and
CMV-seropositivity, as is the case for CD8+ αβ T-cells
[45]. These findings confirm reports generated at “lower
resolution”, by only investigating the Vδ2-negative pool
[31, 32]. We did not identify the effector phenotype
CD27-CD28 + CD45RA ± CD16 ± neither in the Vδ1+
nor in the pool of other (Vδ1-Vδ2-) γδ T-cells, unlike in
the Vδ2+ compartment. As for the Vδ1+ compartment,
we found a higher median frequency of CD27 + CD28-
CD45RA + CD16- cells in CMV-seronegative individuals
in the pool of other (Vδ1-Vδ2-) cells and in the Vδ2+
compartment but there only in the young CMV sero-
negative individuals. Functionality of these cells remains
to be determined by further investigations.
Previously reported associations of the Vδ2-negative
pool, and early and late differentiated memory pheno-
types associated with CMV-specific IgG titer [32], com-
bined with reports describing antibody-dependent anti-
CMV activity of γδ T-cells [29], led us to the conclusion
that examination of the latter might reveal a functional
link between correlations of γδ T-cells and anti-CMV
immunity. However, although we found expression of
CD16 on minorities of various γδ T-cell subsets, mostly
in differentiated phenotypes as earlier reported for the
Vδ2 subset [50] we were not able to identify a clear link
to CMV-seropositivity.
Memory phenotypes in the CD8+ group of Vδ1+ and
Vδ1-Vδ2- γδ T-cells revealed similar associations with
age and CMV as found for total γδ T-cells, despite the
fact that we identified the presence of a CD28 + CD27-
population. Further investigation of CD8+ γδ T-cells is
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required to investigate whether the expression of the
latter is an evolutionary artifact, or of functional import-
ance in anti-CMV immunity as described for αβ CD8+
T-cells [51].
Conclusions
This study presents a uniquely detailed analysis of the γδ
T-cells, in younger and older people with a carefully
characterized background. In the same subjects, we also
assessed αβ T-cells, and found strong associations of
CD8+ αβ T-cells, Vδ1+, other (Vδ1-Vδ2-) with age and
also with CMV-seropositivity. CD4:CD8 ratios were
lower in old CMV-seropositive than in seronegative indi-
viduals. We found increased Vδ1:Vδ2-ratios associated
with CMV in the old, similar to what is reported in can-
cer, supporting the theory of dual reactivity of γδ T-cells.
It remains to be determined whether the increased Vδ1+
compartment in CMV-seropositive individuals might
have similar detrimental impact as reported for the sur-
vival of melanoma patients. The memory differentiation
patterns in the Vδ1+ compartment are similar to the
CD8+ αβ T-cells markedly changed by age and amplified
by the presence of CMV, suggesting an increased mem-
ory compartment of acquired immunity over the life-
time and in particular in association with CMV. On-
going work correlating the presented data with multidis-
ciplinary health, social, psychological and genetic data
from the BASE-II study will help us better understand
the multifactorial immune aging process in a modern
society. More functional and longitudinal studies are
needed to better understand age-associated immune ex-
haustion and the role, if any, that a latent CMV infection
plays therein due the major investment of immune sys-
tem resources to maintain control of latent CMV.
Methods
Subjects
Subjects participated in the Berlin Aging Study II (BASE-
II) with written informed consent and the approval of the
Ethics Committee of the Charité-Universitätsmedizin
Berlin (approval number EA2/029/09). This study is as-
sembling a uniquely rich database of information on each
of the 2200 participating individuals in terms of medical
parameters, genetic analyses, socioeconomic, cognitive
and psychological status, and will allow us to correlate the
immunology reference values reported here with a wide
range of factors influencing health status and mortality at
follow-up [35]. Cryopreserved peripheral blood mono-
nuclear cells (PBMCs) of 217 participants of this study
have been analyzed here. This was a convenience sample
randomly selected form the cohort to include younger
and older CMV-positive and CMV-negative donors. Here,
we included 144 older (62–85 years) and 73 younger (23–
35 years) subjects. Fifty-nine of the young and 85 of
the old individuals were identified as being CMV-
seronegative. Anti-CMV specific IgG titers were deter-
mined semi-quantitatively in the subjects’ plasma
using the CMV IgG ELISA kit from Omega Diagnostic
Group (Scotland).
Flow cytometry
Cyropreserved PBMC samples were thawed, washed and
stained with monoclonal antibodies for the markers of
interest, as described in detail in our standardized
OMIP-20 panel [34]. Samples were acquired using an
LSR II Cytometer (Becton Dickinson). Compensation
was automatically performed with single color controls.
A biological control was included in each analytical run
to ensure comparability between results from different
days. Resulting data were analyzed with FlowJo 9.3.2
(Tree Star). The gating strategy is displayed in Additional
file 1: Figure S8.
Statistics
Statistical analysis was performed with Prism 6.d (Graph
Pad) and SPSS 22 (IBM). Lymphocyte counts derived
from blood count data served as basis for the calculation
of the absolute cell counts of the T-cell populations.
For this, viable single cells identified in the lympho-
cyte gate (Additional file 1: Figure S8) were set as
equal to the clinically-determined lymphocyte counts.
The Mann-Whitney U test was used to compare cell
frequencies between the different groups of interest.
P-values were corrected for multiple testing using the
Bonferroni method.
Additional file
Additional file 1: Table S1. Results of Mann‐Whitney comparisons of
the γδ T‐cell compartments and subsets. Table S2. Results of Mann‐
Whitney comparisons of the CD8+ γδ T‐cell compartments and subsets.
Table S3. Results of Mann‐Whitney comparisons of the αβT‐cell
compartments and subsets. Table S4. Results of Mann‐Whitney
comparisons of the absolute counts for all T‐cell compartments.
Figure S1. Median frequencies and absolute counts of the γδ T‐cell
compartments in young and old CMV‐seropositive (CMV+) and
seronegative (CMV‐) individuals. Figure S2. Differentiation phenotypes of
the Vδ2+ compartment. Figure S3. Differentiation phenotypes of the
Vδ1+ compartment. Figure S4. Differentiation phenotypes of the
Vδ1‐Vδ2‐compartment. Figure S5. Differentiation phenotypes of the
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αβT‐cells. Figure S7. Differentiation phenotypes of the CD4 + αβT‐
cells. Figure S8. Gating Strategy T‐cells. (PDF 1365 kb)
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